A discovery that could protect the eye and the brain

By Jan Jarvis

Eye Research with patient
UNT Health Science Center eye researchers have discovered a chemical that may help prevent irreversible vision loss caused by glaucoma and other retinal diseases.

Nerves in the inner retina carry signals through the optic nerve to the brain for vision recognition, said Abe Clark, PhD., Executive Director of UNTHSC’s North Texas Eye Research Institute.

Abe Clark, UNTHSC
Abe Clark, PhD.

“When the cells in the retina are damaged, then the cells that they connect to in the brain also become damaged,” Dr. Clark said. “When you lose certain nerves in the retina, you lose nerves in the center of the brain.”

But Dr. Clark and his team found that it may be possible to protect both the eye and brain using a chemical known as a JNK inhibitor. The research group exposed cultured retinal cells to several toxic insults while also using a mouse model of retinal ischemic stroke, resulting in nerve cell death in both the retina and brain.

By treating the retina cells with this chemical, the researchers were able to protect against ischemic nerve cell death. The discovery could lead to new therapies to prevent vision loss due to glaucoma and other retinal diseases. The work, which was supported by a grant from the Department of Defense, was published this month in Molecular Neurodegeneration.

“We suggest that the JNK signaling pathway is a prominent and critical path for neurodegeneration due to retinal stroke,” Dr. Clark said. “Treating the nerves with this inhibitor totally protected the retina and the nerves in the brain from functional damage.”

The discovery is believed to be applicable to a number of eye diseases, including glaucoma and diabetic retinopathy, he said. It could also have implications for brain diseases caused by blood flow blockage.

“The retina is part of the brain, and what we might have found is a way to protect the nerves in the brain from similar insults like a stroke,” Dr. Clark said. “We are excited about this as a potential new therapy for treating nerves in diseases with compromised blood flow.”

Recent News

Hill Signing 6627
  • Education
|Sep 6, 2024

HSC and Hill College partner to expand educational opportunities

The University of North Texas Health Science Center at Fort Worth and Hill College on Thursday announced a new partnership aimed at creating pathways to success for students in the region. Hill College is a comprehensive community college with campuses in Hillsboro, Cleburne and Burleson, with a str...
Amany Hassan
  • Research
|Sep 4, 2024

TCOM faculty and staff receive AACOM grant to study innovative AI curriculum integration

The emergence of artificial intelligence is undeniable and the Texas College of Osteopathic Medicine at The University of North Texas Health Science Center at Fort Worth is receiving a grant from the American Association of Colleges of Osteopathic Medicine to study an innovative way of merging AI in...
Img 6647
  • Patient Care
|Sep 3, 2024

Individualization is key: Collaborative care makes all the difference for older adults

Nina Cox was never a cook – her husband did most of the cooking in their household. That was until she was diagnosed with type 2 diabetes and tasked with lowering her A1C to be cleared for knee surgery. With a clear goal in mind, Cox got serious about her health and found support with The Universi...
HSC Sign
  • Education
|Aug 29, 2024

HSC elevates focus with new college names, addition of Graduate School

The University of North Texas Health Science Center at Fort Worth today announced it would launch a new Graduate School to enhance graduate education and rename three of its schools to better clarify their focuses. Effective Sept. 1, HSC will establish a new Graduate School under the leaders...